Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
This study has been terminated.
(funding discontinued by sponsor)
Sponsor:
James Graham Brown Cancer Center
Collaborators:
University of Louisville
Novartis Pharmaceuticals
Information provided by (Responsible Party):
James Graham Brown Cancer Center
ClinicalTrials.gov Identifier:
NCT00265200
First received: December 12, 2005
Last updated: April 5, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |